[Retracted] Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma

Table 6

Comparison of efficacy in the treatment of VRD regimen.

Subgroups	>=VGPR	Sample	Total efficacy rate (%)
VRD original research drug group	88	145	60.69	0.155
VRD generic drug group	94	178	52.81